Dyadic International (DYAI) EBIT (2018 - 2026)
Dyadic International's (DYAI) quarterly EBIT came in at -$1.9 million in Q1 2026, up 4.98% year-over-year from -$1.8 million in Q1 2025, and down 23.88% quarter-over-quarter from -$1.5 million in Q4 2025.
Analysis
Dyadic International (DYAI) EBIT (2018 - 2026) Analysis & Trends
Dyadic International has disclosed EBIT across 9 years of filings, most recently posting -$1.9 million for Q1 2026.
- In Q1 2026, EBIT rose 4.98% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$7.1 million (down 22.76% YoY), while the FY2025 annual figure was -$7.2 million, down 21.9% from the prior year.
- EBIT came in at -$1.9 million for Q1 2026 at Dyadic International, down from -$1.5 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$202614.0 in Q3 2024 to a low of -$3.3 million in Q2 2022.
- Average EBIT over 5 years is -$2.0 million, with a median of -$2.0 million recorded in 2025.
- Year-over-year, EBIT soared 99.92% in 2022 and tumbled 850.26% in 2025.
- Over 5 years, EBIT stood at -$2.2 million in 2022, then rose by 3.16% to -$2.2 million in 2023, then climbed by 29.45% to -$1.5 million in 2024, then dropped by 0.38% to -$1.5 million in 2025, then decreased by 23.88% to -$1.9 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$1.9 million in Q1 2026, -$1.5 million in Q4 2025, and -$1.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.59 Bn | 192.60 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 180.21 Bn | 177.03 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 131.41 Bn | 123.56 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.94 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Argenx Se | 60.60 Bn | 55.41 Bn | 1.37 Bn | 493.00 Mn |
| 6 | Moderna | 53.61 Bn | 48.47 Bn | 52.00 Mn | -815.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.49 Bn | 30.18 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 31.83 Bn | 30.54 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Roivant Sciences | 29.14 Bn | 29.14 Bn | 1.16 Mn | -365.99 Mn |
| 10 | Dyadic International | 18.44 Mn | 10.48 Mn | - | -1.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -1.90 Mn |
| Dec 31, 2025 | -1.54 Mn |
| Sep 30, 2025 | -1.93 Mn |
| Jun 30, 2025 | -1.73 Mn |
| Mar 31, 2025 | -2.00 Mn |
| Dec 31, 2024 | -1.53 Mn |
| Sep 30, 2024 | -202,614.00 |
| Jun 30, 2024 | -2.04 Mn |
| Mar 31, 2024 | -2.13 Mn |
| Dec 31, 2023 | -2.17 Mn |
| Sep 30, 2023 | -1.72 Mn |
| Jun 30, 2023 | -2.29 Mn |
| Mar 31, 2023 | -2.05 Mn |
| Dec 31, 2022 | -2.24 Mn |
| Sep 30, 2022 | -1.86 Mn |
| Jun 30, 2022 | -3.32 Mn |
| Mar 31, 2022 | -2.74 Mn |
| Dec 31, 2021 | -4.22 Mn |
| Sep 30, 2021 | -3.32 Mn |
| Jun 30, 2021 | -3.87 Mn |